J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiang, S.-Q.
Right arrow Articles by Sniderman, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiang, S.-Q.
Right arrow Articles by Sniderman, A. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 40, 1655-1663, September 1999
Copyright © 1999 by Lipid Research, Inc.


Original Article

Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase

Shi-Qin Xianga, Katherine Cianflonea, David Kalanta, and Allan D. Snidermana
a Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Center, Montreal, Quebec H3A 1A1, Canada

Correspondence to: Allan D. Sniderman

In comparison to very low density lipoprotein (VLDL), chylomicrons are cleared quickly from plasma. However, small changes in fasting plasma VLDL concentration substantially delay postprandial chylomicron triglyceride clearance. We hypothesized that differential binding to lipoprotein lipase (LPL), the first step in the lipolytic pathway, might explain these otherwise paradoxical relationships. Competition binding assays of different lipoproteins were performed in a solid phase assay with purified bovine LPL at 4°C. The results showed that chylomicrons, VLDL, and low density lipoprotein (LDL) were able to inhibit specific binding of 125I-labeled VLDL to the same extent (85.1% ± 13.1, 100% ± 6.8, 90.7% ± 23.2% inhibition, P = NS), but with markedly different efficiencies. The rank order of inhibition (Ki) was chylomicrons (0.27 ± 0.02 nM apoB) > VLDL (12.6 ± 3.11 nM apoB) > LDL (34.8 ± 11.1 nM apoB). By contrast, neither triglyceride (TG) liposomes, high density lipoprotein (HDL), nor LDL from patients with familial hypercholesterolemia were efficient at displacing the specific binding of 125I-labeled VLDL to LPL (30%, 39%, and no displacement, respectively). Importantly, smaller hydrolyzed chylomicrons had less affinity than the larger chylomicrons (Ki = 2.34 ± 0.85 nM vs. 0.27 ± 0.02 nM apoB respectively, P < 0.01). This was also true for hydrolyzed VLDL, although to a lesser extent. Chylomicrons from patients with LPL deficiency and VLDL from hypertriglyceridemic subjects were also studied.

Taken together, our results indicate an inverse linear relationship between chylomicron size and Ki whereas none was present for VLDL. We hypothesize that the differences in binding affinity demonstrated in vitro when considered with the differences in particle number observed in vivo may largely explain the paradoxes we set out to study.—Xiang, S-Q., K. Cianflone, D. Kalant, and A. D. Sniderman. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. J. Lipid Res. 1999. 40: 1655;–1662.

Supplementary key words: binding, lipoprotein lipase, lipoproteins, triglyceride clearance


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
V. Petit, L. Arnould, P. Martin, M.-C. Monnot, T. Pineau, P. Besnard, and I. Niot
Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse
J. Lipid Res., February 1, 2007; 48(2): 278 - 287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
I. Duivenvoorden, P. J Voshol, P. C. Rensen, W. van Duyvenvoorde, J. A Romijn, J. J Emeis, L. M Havekes, and W. F Nieuwenhuizen
Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice.
Am. J. Clinical Nutrition, August 1, 2006; 84(2): 312 - 321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Werner, R. Havinga, F. Perton, F. Kuipers, and H. J. Verkade
Lymphatic chylomicron size is inversely related to biliary phospholipid secretion in mice
Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1177 - G1185.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. R. Barrows and E. J. Parks
Contributions of Different Fatty Acid Sources to Very Low-Density Lipoprotein-Triacylglycerol in the Fasted and Fed States
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1446 - 1452.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Heeren, U. Beisiegel, and T. Grewal
Apolipoprotein E Recycling: Implications for Dyslipidemia and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 442 - 448.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Nilsson and R.-D. Duan
Absorption and lipoprotein transport of sphingomyelin
J. Lipid Res., January 1, 2006; 47(1): 154 - 171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. V Sekhar, F. Jahoor, H. J Pownall, K. Rehman, J. Gaubatz, D. Iyer, and A. Balasubramanyam
Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome
Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1405 - 1410.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Conde-Knape, K. Okada, R. Ramakrishnan, and N. S. Shachter
Overexpression of apoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted mice than in apoB-100-only mice
J. Lipid Res., December 1, 2004; 45(12): 2235 - 2244.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y.-G. Niu, D. Hauton, and R. D. Evans
Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates
J. Physiol., July 1, 2004; 558(1): 225 - 237.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
V. Pruneta-Deloche, A. Sassolas, G. M. Dallinga-Thie, F. Berthezene, G. Ponsin, and P. Moulin
Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes
J. Lipid Res., May 1, 2004; 45(5): 859 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Faraj, A. D. Sniderman, and K. Cianflone
ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes
J. Lipid Res., April 1, 2004; 45(4): 657 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Cianflone, R. Zakarian, C. Couillard, B. Delplanque, J.-P. Despres, and A. Sniderman
Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance
J. Lipid Res., January 1, 2004; 45(1): 124 - 131.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. K Fried and S. P Rao
Sugars, hypertriglyceridemia, and cardiovascular disease
Am. J. Clinical Nutrition, October 1, 2003; 78(4): 873S - 880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. S. Augustus, Y. Kako, H. Yagyu, and I. J. Goldberg
Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E331 - E339.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yagyu, E. P. Lutz, Y. Kako, S. Marks, Y. Hu, S. Y. Choi, A. Bensadoun, and I. J. Goldberg
Very Low Density Lipoprotein (VLDL) Receptor-deficient Mice Have Reduced Lipoprotein Lipase Activity. POSSIBLE CAUSES OF HYPERTRIGLYCERIDEMIA AND REDUCED BODY MASS WITH VLDL RECEPTOR DEFICIENCY
J. Biol. Chem., March 15, 2002; 277(12): 10037 - 10043.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. Kalant, S. Phélis, B. A. Fielding, K. N. Frayn, K. Cianflone, and A. D. Sniderman
Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women
J. Lipid Res., December 1, 2000; 41(12): 1963 - 1968.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.